Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study

Active, not recruitingOBSERVATIONAL

Enrollment

1,300

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

January 8, 2025

Study Completion Date

January 8, 2025

Conditions

Atrial FibrillationStroke, Ischemic

Interventions

DRUG

Anticoagulation Therapy

Long term oral anticoagulation with VKA (vitamin K antagonist) or NOAC (non-vitamin K oral anticoagulant)

Trial Locations (1)

Turku University Hospital, Heart Center, Turku

All Listed Sponsors

lead

University of Turku

OTHER